These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12419081)

  • 1. What is tibolone--and is it a SPEAR?
    Purdie DW
    Climacteric; 2002 Sep; 5(3):236-9. PubMed ID: 12419081
    [No Abstract]   [Full Text] [Related]  

  • 2. 7alpha-Methyl-ethinyl estradiol is not a metabolite of tibolone but a chemical stress artifact.
    Dröge MJ; Oostebring F; Oosting E; Verheul HA; Kloosterboer HJ
    Menopause; 2007; 14(3 Pt 1):474-80. PubMed ID: 17237734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of tibolone to 7alpha-methyl-ethinyl estradiol using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry: interpretation and clinical implications.
    Zacharia LC; Jackson EK; Kloosterboer HJ; Imthurn B; Dubey RK
    Menopause; 2006; 13(6):926-34. PubMed ID: 17006378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the endometrium in patients treated with tibolone.
    Yazigi R; Sahid S; Contreras L; Rodriguez T
    Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
    Jacobsen DE; Samson MM; Kezic S; Verhaar HJ
    Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms.
    Liu JH
    Am J Med; 2005 Dec; 118 Suppl 12B():88-92. PubMed ID: 16414332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
    Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
    Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestagenic effects of tibolone are target gene-specific in human endometrial cells.
    Zhang W; Mazella J; Kloosterboer HJ; Tseng L
    J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tibolone on nuclear receptors in human endometrial cells.
    Zhang W; Mazella J; Kloosterboer HJ; Tseng L
    Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIBERATE tibolone trial in breast cancer survivors.
    Speroff L
    Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
    [No Abstract]   [Full Text] [Related]  

  • 11. Does tibolone exacerbate atherosclerosis?
    Clarkson TB
    Eur Heart J; 2006 Mar; 27(6):635-7. PubMed ID: 16415302
    [No Abstract]   [Full Text] [Related]  

  • 12. Tibolone.
    Reynir Tomas G
    Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349
    [No Abstract]   [Full Text] [Related]  

  • 13. 3beta-OH-tibolone acutely dilates rat muscle arterioles similar to 3alpha-OH-tibolone.
    Korstjens IJ; van der Mooren MJ; Kloosterboer HJ; Sipkema P
    Menopause; 2008; 15(2):386-7. PubMed ID: 18000470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats.
    Yang X; Li YZ; Mao Z; Gu P; Shang M
    Chin Med J (Engl); 2009 Feb; 122(4):381-5. PubMed ID: 19302740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
    Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
    J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
    [No Abstract]   [Full Text] [Related]  

  • 16. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P; Speroff L;
    Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies.
    Coomarasamy A
    BJOG; 2008 Jun; 115(7):919. PubMed ID: 18485174
    [No Abstract]   [Full Text] [Related]  

  • 18. Tibolone is not used as a first-line therapy: implications for the Million Women Study analysis.
    Seeley T
    J Br Menopause Soc; 2006 Jun; 12(2):81. PubMed ID: 16776860
    [No Abstract]   [Full Text] [Related]  

  • 19. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 20. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.